These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8757470)

  • 1. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
    Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
    Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
    Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
    Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
    Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
    Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
    Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical expression of p53 oncoprotein in large bowel adenomas and carcinomas].
    Roa JC; Villaseca MA; Roa I; Araya JC; Okayasu I; Flores P; Flores M
    Rev Med Chil; 1997 May; 125(5):523-9. PubMed ID: 9497572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia.
    Kaklamanis L; Savage A; Mortensen N; Tsiotos P; Doussis-Anagnostopoulou I; Biddolph S; Whitehouse R; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):10-4. PubMed ID: 8691332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
    Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
    J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
    Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence.
    Yang HB; Chow NH; Sheu BS; Chan SH; Chien CH; Su IJ
    Anticancer Res; 1999; 19(1B):727-30. PubMed ID: 10216484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
    Han HS; Park YM; Hwang TS
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.
    Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T
    Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
    Darmon E; Cleary KR; Wargovich MJ
    Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
    Agui T; McConkey DJ; Tanigawa N
    Anticancer Res; 2002; 22(3):1769-76. PubMed ID: 12168867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
    Sundblad AS; Chumbita RL; Zoppi JA
    Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.